Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19Hanny Al‐Samkari, Shruti Gupta, Wei Wang et al.|Annals of Internal Medicine|2021Cited by 140
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19Alexi Vasbinder, Salim S. Hayek, Rafey Feroze et al.|Diabetes Care|2022Cited by 74
Cardiovascular Events After Hematopoietic Stem Cell TransplantAlexi Vasbinder, Salim S. Hayek, Christopher W. Hoeger et al.|JACC CardioOncology|2023Cited by 46
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19Alexi Vasbinder, Chelsea Meloche, Tariq U. Azam et al.|Circulation Cardiovascular Quality and Outcomes|2022Cited by 34
Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID‐19Michael Pan, Alexi Vasbinder, Élizabeth Anderson et al.|Journal of the American Heart Association|2021Cited by 29